Business, Entertainment, Markets, Research Reports - September 3, 2022

Adani Ports made a net profit of Rs. 1072 crore.

Adani Ports and Special Economic Zone (APSEZ) posted a 16.09% drop in consolidated net profit at 1,072.38 crore for the quarter ended Q1FY23 compared to 1,277.99 crore in the same period last year. However, Q1 PAT climbed 4.72% from 1,024 crore in the preceding quarter. The growth was double-digit sequentially. Approximately 70% of revenues are contributed by its port operations. The remainder is led by harbour, logistics, and others, which account for 11%, 7%, and 5%, respectively.

Strong growth with inorganic acquisition

There was a higher realisation that bulk volume lifted operational performance. The revenues remained flat YoY at 4638 crore. As margins expanded, absolute EBITDA increased 13% to 3006 crores. However, PAT de-grew 19% to 1072 crore due to a forex loss of 1201 crore. The strong organic growth was coupled with the efficient incorporation of inorganic acquisitions. APSEZ, by integrating logistics operations both vertically and horizontally, has built a strong moat around the business.

As APSEZ embarks on becoming India’s largest integrated transport utility company by 2030, it is strengthening its capabilities in all logistics segments. It will offer end-to-end service to its customers, thereby capturing a higher wallet share and also making the cargo sticky in nature. DFC connectivity to Mundra (medium-term normalization) to provide faster port evacuation and transit time.

The management expects thermal and coking coal volumes to grow in FY23 in spite of comfortable thermal coal inventory levels in power plants. Construction on 4.5 million square feet of warehousing capacity has begun in Mundra, Moraiya, Ranoli, and Palwal. GPWIS cargo volumes have doubled YoY to 3.11 MMT and APSEZ has ordered more trains under the framework (total order count at 37) Gangavaram NCLT approval is expected to be completed by the current The quarter following which the numbers would be consolidated with APSEZ, beginning April 1, 2021.The management is not seeing any slowdown in any segment and expects its run rate of 30 MMT per month to continue in FY22.

During Q1, the management took a price hike, renegotiated contracts with its customers, and expects the same to flow from Q2 onwards Overall, the management has guided for a 1 to 1.5 pp incremental rise in EBITDA margins in the medium to long term. In spite of strong growth in its rail Exim volumes, the management is still keen on the Concor acquisition as it expects higher penetration and more Exim movement going forward. The management would soon come up with its strategy around last-mile logistics.

Valuations:

The company has an EPS of Rs. 5.08 for the period ended June 30, 2022 as compared to Rs. 6.40 for the period ended June 30, 2021. The ROCE and ROE stood at 11.2% and 14.7%, respectively. The stock is trading at a P/E of 37.1x and a 5-year P/E of 19.6x. The EBITDA multiple is 19.9x and has an interest coverage ratio of 3.14x. The price to book ratio is at 4.69x. The scrip was trading at Rs.850, up by 1.46% on Friday.

0 Comment

Jio’s Giant Leap: Reliance Confirms IPO in Early 2026

Uncategorized - September 2, 2022

Reliance Industries earned a revenue of Rs. 223,113 cr.

During the June 2022 quarter, Reliance Industries posted a consolidated net profit of 17,955 crore, up from 12,273 crore in June 2021, up by 46.3%. The revenue jumped by 54.5% to 223,113 crore from 144,372 crore in Q1 last year. Meanwhile, EBITDA was at 37,997 crore in Q1 FY23 as against 23,368 crore in Q1 FY22 and 31,366 crore in Q4 FY22. The margin improved to 17.3% compared to 16.7% in Q1 FY22 and 15.1% in Q4 FY22.

Best quarterly performance for Jio and Retail:

This was facilitated by higher contributions from fashion and lifestyle and consumer electronics segment sales. The segment added nearly 792 stores, bringing its total store count to 15,866 stores at the end of Q1FY23. Digital and new commerce increased twofold year on year and now account for 19% of total revenue. The company’s own-brand consumer electronics products portfolio continues to scale up. In Q1 FY23, sales of in-house consumer electronic brands increased by 6.0x year on year. Fashion and lifestyle have experienced strong growth in sales, driven by regional festivities and promotions. The average bill value (ABV) and conversion ratio are at an all-time high in this segment.

With increasing partnerships, Ajio’s online sales platform added nearly 660 brands in the quarter. Ajio Luxe sales rose by 6.0x YoY with the presence of 400 brands and over 38,000 options on the Ajio platform. Its in-house brands contributed 30% of total sales in the category in Q1FY23 vs. 27.0% in Q1FY22. It introduced 14 new in-house brands in Q1FY23. In Q1FY23, urban ladder and pharma retail sales increased 2.0x year on year.The merchant base has increased by 50% YoY and Reliance Retail has ramped up in 2,400 towns.

RIL is a preferred downstream player with a strong growth outlook for consumer-centered businesses, and further value unlocking in digital and retail businesses would add to shareholders’ returns in the coming years. Expecting the 5G network to further skew the telecom market in favour of Jio, Its growth prospects look promising, led by subscriber accumulation post churn and regular tariff surg. The launch of 5G is to be looked forward to. RIL is an ideal pick given its dominant position across business verticals. However, we expect 17% annual growth in EBITDA over FY22-FY25, driven by a 6% CAGR for the cyclical business and a 26% CAGR for the consumer business. The increase in value of energy business will offsets decrease in consumer business.

Jio stands to garner connectivity and IOT revenues along with a significant share of the market. Jio’s growth prospects look promising, led by subscriber additions post churn and regular tariff hikes. The company will include the migration of high-end customers from competitors due to superior user experience and balance from the upgrade to 5G smartphones.

Valuations:

The company has reported an EPS of Rs. 26.54 for the period ended June 30, 2022 as compared to Rs. 19.36 for the period ended June 30, 2021. The ROCE and ROE stood at 9.42% and 8.1%, respectively. The stock is trading at a P/E of 26.9x, which is not expensive, and a 5-year P/E of 17.9x. The EBITDA multiple is 14.6x and has an interest coverage ratio of 7.01x. The price to book ratio is at 2.22x, which has a book value of Rs.1152. The scrip was trading at Rs.2560, down by 2.94% on Thursday.

0 Comment

Business, Entertainment, Markets, Result Updates - August 30, 2022

Sun TV reported a net profit of Rs. 493.99 cr.

The Chennai-based company reported a 35.32% rise in consolidated profit after tax to Rs 493.99 crore in the first quarter that ended June. The company had reported a profit after tax of Rs 365.03 crore in the April-June period a year ago. Sun TV’s revenue from operations rose 48.88 percent to Rs 1,219.14 crore in the latest June quarter. It was at Rs. 818.587 crores in the year-ago period. Sun TV’s board also approved an interim dividend of 100 percent, which is Rs 5 per share.

Consistent growth will be aided by strong flows.

Sun TV’s ramp-up in viewership in key markets, increasing presence, and increasing foothold in other regional languages, such as Marathi, are positive. Strong flows from IPL monetization and potential from other franchises are accretive. It added that Sun TV is expected to witness continued growth from advertising as big spenders like FMCG ramp up spending, with a buy tag and Rs 642 as a target price. Increasing competition and OTT aggression are key monitorables, it said. They pare down our revenue estimates for FY 23–24 by factoring in slightly lower ad growth. The core broadcasting business is trading at a low valuation of 6.5 times. The digital business also remains a laggard, with no fresh investments in OTT originals. The movie catalogue is large, but a sizable original catalogue is needed to scale up the digital business in the highly fragmented Indian market. OTT content spending remains a key concern, while film content spending will create volatility in earnings.

They also do not have a management outlook on content strategy, margins, growth outlook, and capital allocation ahead, which restricts us from turning constructive, despite lucrative valuations. There is an overall viewership share improvement, which has dipped in recent times. They expect a recovery in key markets like Tamil, Telugu, and Kannada to be a growth driver. The marked ramp-up in SunNXT content is lagging because content spending is lagging.

Valuations:

The company has reported an EPS of Rs. 12.53 for the period ended June 30, 2022, as compared to Rs. 9.27 for the period ending June 30, 2021. The ROCE and ROE stood at 29.1% and 21.6%, respectively. The stock is trading at a P/E of 11.2x, which is not expensive, and a 5-year P/E of 12.2x. a 6.55x EBITDA multiple and a 71.4x interest coverage ratio The price-to-book ratio is at 2.46x, which has a book value of Rs.207. The scrip was trading at Rs. 504, up by 1.43% on Monday.

0 Comment

Sensex Jumps 450 Points Amid Renewed US-China Trade Hopes and Strong Sectoral Buying

Business, Markets, Result Updates - August 30, 2022

Saregama PAT was Rs. 41 cr. in Q1 FY23.

Saregama PAT was Rs. 41 cr. in Q1 FY23.

PAT increased by 52% year on year to Rs. 41 Cr. in Q1 FY23. The company’s operating revenue rose 61% YoY to Rs. 169 Cr. in Q1 FY23. Saregama’s operating income before content charge, interest and depreciation (OIBCID) rose 54% to Rs. 64 r. in Q1 FY23 from Rs. 42 Cr. in the corresponding quarter last year. The Q1 FY23 PBT stood at Rs. 55 Cr. as against Rs. 36 Cr. in the corresponding quarter last year, with a 52% growth YoY.

Current and future quarter work:

During this quarter, the company launched the music of Mahesh Babu’s Sarkaru Vaari Paata in Telugu; Operation Romeo and Ittu Si Baat in Hindi with music from singers like Arijit Sigh and Jubin Nautiyal. Saregama also released multiple “Originals” songs sung by Neeti Mohan, Stebin Ben, etc. Overall, the company released 186 films and non-film songs across Hindi, Bhojpuri, Gujarati, Punjabi, Tamil, Telugu, Malayalam, Marathi, and Bengali languages. The other highlight of the quarter was the use of songs by brands like Dabur, Vogue Eyewear, TVF, One Card, PhonePe, etc. in their ad films.

With retail markets opening up, Carvaan continued to regain its momentum. The company sold 98k units in Q1, compared to 45k last year. During the last fortnight of June, they also started test marketing two new variants, namely, Music Bar with Karaoke and Carvaan Mobile.

They have completed shooting of our first Malayalam film, “Padavettu,” starring Nivin Pauly. The shooting begins for the next Malayalam film “Kaapa” starring the superstar Prithviraj Sukumaran and the shooting of the first Punjabi film “Oye Makhana” starring Amy Virk. “Hunter-The Invisible Women”, starring Suniel Shetty, is expected to be released soon. Roja and Anbe Vaa are the slot leaders in their respective prime time slots. The Saregama TV Shows YouTube channel garnered 38 million views in Q1FY23. Star India has licensed the remake rights of the TV series “Roja” for the Hindi language. The company continues to create short video content relating to “Bhakti” and “Yoga” exclusively for YouTube. In addition to concerts, the vertical will develop musical theatre IP based on the stories and songs of some of the greatest films in our catalogue, like Disco Dancer and Karz.

Valuations:

The company has reported an EPS of Rs. 2.15 for the period ended June 30, 2022 as compared to Rs. 1.56 for the period ended June 30, 2021. The ROCE and ROE stood at 22.1% and 16.2%, respectively. The stock is trading at a P/E of 46.4x, which is not expensive, and a 5-year P/E of 24.7x. Saregama has an EBITDA multiple of 30.4x and an interest coverage ratio of 43.6x. The price to book ratio is at 5.61x, which has a book value of Rs.71.4. The scrip was trading at Rs. 401, down by 1.43% on Monday.

0 Comment

NATO Eases Defence Spending Demand Following Spain's Objection to 5% GDP Commitment

Business, Markets, Result Updates - August 26, 2022

Ambuja Cements reported a net profit of Rs. 752 for the fiscal year ending June 2022.

Cement maker Ambuja reported a 14.2% drop in consolidated net profit to Rs 752 crore for the quarter ended June 2022 compared to June 2021. This was due to higher power and fuel costs and freight expenses, while the revenue climbed 15.1% YoY to Rs 8,033 crore.

The consolidated net sales rose 15.1% to Rs 7,943 crore in the April-June period versus the same period last year, while earnings before interest, tax, depreciation and amortisation (Ebitda) fell 39% to Rs 1,115 crore during the quarter. The company’s Ebitda margin stood at 14% during the quarter, a sharp fall from the 26.5 per cent reported in the same period last year. Last week, ACC’s net profit fell 60 percent year-on-year to Rs 227 crore, while net sales grew 15 percent over the year-ago period to Rs 4,468 crore.

Future Prospects

The company reported total expenses of Rs 7,276.72 crore in the June quarter. The expenses increased by 33.09% from Rs 5,467.33 crore in the year-ago period. The sales volume was up 15.1% in the April-June quarter at 7.39 million tonnes per annum (MTPA) from 6.42 MTPA in the corresponding quarter. The company recorded robust volume growth of 15% and top-line growth of 18% in the quarter. However, the April to June 2022 quarter was impacted by rising fuel prices and related inflationary impacts.

The company invested in a 3.2 MTPA brownfield clinker at Bhatapara and a 7.0 MTPA cement grinding expansion at its existing locations (Sankrail and Farakka). A greenfield grinding unit at Barh, Bihar. The company is acquiring limestone reserves to support long-term growth. The recovery in domestic economic activity is gathering strength. Rural consumption should benefit from the likely normal monsoon. The investment activity is expected to be supported by improving capacity utilisation, the government’s capex push, and strengthening bank credit. Geopolitical tensions, elevated commodity prices, supply bottlenecks, and tightening global financial conditions are key factors to look at.

Valuations:

The EPS stood at Rs. 3.79 for June 2022, which was at Rs. 3.32 in March 2022 and Rs. 4.42 in June 2021. The stock has a ROCE of 22.1% and a ROE of 11.8%. The P/E ratio is now 33.1x, up from 20.9x five years ago. The EBITDA is at 13.1x and the return on assets is at 8.94%. The interest coverage ratio is 29.2x and the asset turnover ratio is 0.68. The share is trading at a price of Rs.402, up by 1.35%.

0 Comment

Shipa Medicare reported an 85 lakh net profit.

Business, Equities, Markets, Research Reports - August 26, 2022

Shilpa Medicare reported an 85 lakh net profit.

Shipa Medicare reported an 85 lakh net profit.

Shipa Medicare has reported a total income of Rs. 269.2583 crores during the period ended June 30, 2022 as compared to Rs. 346.0867 crores during the period ended March 31, 2022. The company has posted a net profit or (loss) of Rs. 0.8485 crores for the period ended June 30, 2022 as against a net profit or (loss) of Rs. 29.5490 crores for the period ended March 31, 2022. Gross margins declined in Q1FY23 due to pricing pressures in both the API and formulation segments.

First domestic player to launch Adalimumab :

To improve cost efficiencies and improve margin profile, the company is working on process changes, backward integration of intermediates, and increasing the scale of operations.In the API business, the company intends to continue its focus on oncology molecules while reducing its dependence on niche non-onco molecules. Shilpa has set up a dedicated block which includes R&D and production blocks. It intends to complete 6 molecules, 2 in FY23 and 4 in FY24, for the exhibit batches. The company is working on specialised polymers and believes there is enough opportunity to grow in the segment. Management expects phase-1 studies to start by CY22-end and complete them in 9 months. Shilpa has been able to stabilise the product for 1 kL. The molecule will start with the grade market, which has small potential, and then move towards formulations. Shilpa intends to give some time for the business to stabilise before looking at an IPO. Shilpa has largely completed the remediation of the Jadcherla formulations unit. Third-party audits of the plant have also concluded without any data integrity issues. Company is constantly in touch with the USFDA with regular updates. On approval, Shilpa is expected to become the first domestic company to launch high-concentration Adalimumab. Given the studies were conducted in the EU, the company intends to pursue launches in the RoW market. The domestic market size for the molecule is Rs. Certain expenses have been capitalised, which will impact P&L, but they are not significant. Capex: Rs 4 billion was earmarked for the Albumin project, of which Rs 1.2 billion has been utilised. Apart from maintenance, there is no major capex for the formulations plant. The Capex for the API business will depend on capacities and the management expects an expense of Rs400mn-500mn.

The company does not plan more investments in biologics. Onco and other API segments witnessed one-offs during Q1FY23 on account of Ind-Asu requirements and trading revenues, respectively. We believe performance will remain steady going forward, with the USFDA resolution remaining the key to faster growth. Key upside risks are early resolution of the import alert, high-value launches in formulations, and quick success in biosimilars.

Valuations:

EPS is at Rs. 0.10 for the June quarter as compared to Rs. 3.40 in the March quarter and Rs. 0.2 in the June 2021 quarter. The ROCE and ROE are at 5.58% and 3.35%, respectively. The EBITDA stood at 19.2x while the price to book ratio was at 1.81x. The stock was trading at a P/E ratio of 62.0x. The scrip was at Rs.388 on Thursday, up by 0.90%.

0 Comment

BHEL Posts Strong Q2 FY26 Comeback as Profit Rebounds

Business, Editorials, Markets, Research Reports - August 25, 2022

Bhageria India reported a net profit of Rs. 2.38 cr.

The net sales were at Rs 108.12 crore in June 2022, down 4.33% from Rs 113.02 crore in June 2021. The quarterly net profit stood at Rs. 2.38 crore in June 2022, down 81.65% from Rs. 12.96 crore in June 2021. The EBITDA stands at Rs. 11.99 crore in June 2022, down 49.83% from Rs. 23.90 crore in June 2021.

Are retained earnings used effectively?

The company earned revenue of Rs.99.59 Cr from the chemical segment, Rs.8 Cr. from solar power and Rs.0.4 Cr. from other segments for the year ending in March 2021. The EBIT from the chemical segment was Rs. 2.43 Cr., Rs. 3.75 Cr. from the solar power segment and Rs. 0.86 from other. The company incurred a finance cost of Rs. 1.08 cr. and other unallocated expenditure of Rs. 2.38 cr. The surplus current assets suggest that Bhageria Industries has a conservative balance sheet and could probably eliminate its debt without much difficulty. Succinctly put, Bhageria Industries boasts net cash, so it’s fair to say it does not have a heavy debt load.

Any business needs free cash flow to pay off debt; accounting profits just don’t cut it. Bhageria Industries has net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Bhageria Industries created free cash flow of 14% of its EBIT. That level of cash conversion undermines its ability to manage and pay down debt. While it is always sensible to investigate a company’s debt, in this case, Bhageria Industries has 152.4m in net cash and a decent-looking balance sheet. So we are not troubled with Bhageria Industries’s debt use. However, not all investment risk resides on the balance sheet.

Valuations:

EPS is at Rs.0.55 for the June quarter as compared to Rs.4.17 in the March quarter and Rs.2.39 in the June 2021 quarter. The ROCE and ROE are at 19.2% and 14.7%, respectively. The EBITDA stood at 6.48x while the price to book ratio was at 1.46x. The stock was trading at a P/E ratio of 12.3x. The scrip was at Rs.170 on Thursday, up by 0.18%.

0 Comment

Hindalco Industries plans to invest Rs. 15,000 crore in Madhya Pradesh

Business, Editorials, IPO research, Markets, Research - August 25, 2022

ONCG made a profit of Rs. 15205 Cr.

ONCG reported a standalone profit of Rs 15,205.85 crore for the month of June 2022, up 251% compared to the year-ago period, driven by strong operating performance and top-line growth. The standalone profit in Q1 FY22 stood at Rs 4,334.75 crore. The standalone revenue for the June FY23 quarter grew by 84% to Rs 42,321 crore compared to the corresponding period last fiscal. ONGC had a 91% year-on-year growth in its offshore business at Rs 27,990.4 crore and its onshore business increased by 72% to Rs 14,330.3 crore during the quarter.

Consistent natural gas output

At 1.63 million tons, Oil and Natural Gas Corporation (ONGC) produced 1.7% less oil due to lower output from western offshore. The production decreased by 12.34% in fields run by private businesses. However, compared to April through July 2021, when output was 9.96 million tons, it was only slightly lower during the first four months of the current fiscal, which started on April 1. On August 4, Oil Minister Hardeep Singh Puri tweeted that the trend of diminishing crude oil production had changed. The data from the ministry showed that Vedanta’s Rajasthan block had a lower output than ONGC’s oilfields in Gujarat and Assam.

The natural gas output was nearly steady in July at 2.88 billion cubic metres but was 3.4% higher from April to July at 11.43 bcm. The refineries processed 83.96 million tonnes of crude oil between April and July, operating at 103.87% of their capacity, compared to an operating rate of 92.01% for processing 76.64 million tons. Fuel production increased by 6.23% in July to 21.97 million tonnes and by 11.67% from April to July to 90 million tons.

The company has fixed August 19th, 2022 as the “Record Date” for determining members eligible to receive a final dividend of 3.25 per share (i.e., @ 65%) for the financial year 2021-22.

Valuations:

The EPS stood at Rs. 12.09 for Q1 FY23. The price to book ratio was at 0.73x. The return on assets was at 12.3%. The interest coverage ratio was 24x for June 2021. The EBITDA was at 2.50x. The ROCE and ROE were at 18.0% and 18.2%, respectively. The stock is trading at 3.35x while the five-year P/E ratio is at 7.51x. The scrip closed at Rs.136, up by 1.68% on Wednesday.

0 Comment

Everest Kanto reported a total revenue of Rs. 380 Cr.

Business, Editorials, Equities, Result Updates - August 24, 2022

Insecticide India reports a net profit of Rs. 38 Cr.

In the June quarter, Insecticide India reported total sales of Rs. 561 Cr. The company’s net profit stood at Rs 38 crores as compared to Rs 22 crores in the March quarter. EBITDA was 66 crores in Q1 FY23, compared to 42 crores in Q4 FY22 and 61 crores in Q1 FY22, with EBITDA margins contracting to 90 basis points. In the first quarter of FY23, B2C, B2B, and exports contributed 66%, 29%, and 5%, respectively. The better product mix, coupled with price hikes in the recent past, led to a gross margin improvement of 70bps. The Institutional (B2B) category grew by +30% YoY in 1Q.

New launches to increase demand:

Insecticide India has launched 3 new products in 1Q and intends to launch another 6 products in FY23E. There is a CAPEX of Rs1.1bn largely behind, and the technical synthesis plant is to commence at the end of the year. Going forward, we expect the business to pick up with new launches, a better margin profile of in-licensing, the inauguration of new capacities, and backward integration projects. The management expects double-digit revenue growth with at least 100 bps improvements in margins to be led by better contributions from new product launches and superior product mix in FY23E.

In 1Q FY23, the ITI (innovation turnover index) index was at 12.2%. They have recently received four patents for fungicides and pesticides, with a few more patents to be granted in the subsequent quarters. The company launched 3 new products in 1QFY23: Torry (Maize herbicide), Sargent Xpress (insecticide), and Himax (non-selective weedicide). While the revenues from the recently launched products in FY22-Hachiman, Oxim, and Shinwa grew 3x in 1QFY23. There has been a marginal increase in the CAPEX budget on account of inflationary costs and non-budgeted incidental expenditures. The technical synthesis plant at Dahej is expected to commence operations by the end of 1HFY23. We expect similar growth momentum in FY24. However, the company lowered export revenue guidance by 25% to Rs. 150 crore.

Valuation:

The EPS stood at Rs.54.0, while the stock is trading at a P/E of 18.5X. The 5-year P/E stood at 11.2x. The EBITDA was at 11.6x and the interest coverage ratio was at 25.7x. The ROCE was at 16% and the ROE was at 12.7%. The scrip closed at Rs.1000, down by 1.06% on Tuesday.

0 Comment

Business, Equities, Markets, Result Updates - August 20, 2022

Bata India reported a 71.82% increase in consolidated net profit of Rs 119.37 crores

Bata India Ltd. posted its highest ever quarterly sales:

Bata India reported a 71.82% increase in consolidated net profit of Rs 119.37 crores for the first quarter, as the shoemaker achieved the “highest ever quarterly sales”. The company posted a net profit of Rs 69.47 crores in June 2021. Its revenue during the June quarter was Rs 943.01 crore, up over three-fold from Rs 267 crore in the pandemic-hit corresponding quarter of FY22. Bata India’s total expenses were at Rs 792.58 crore, up two-fold in Q1FY23 as against Rs 371.61 crore a year ago. During the quarter, the company continued to improve cost structures and increase efficiencies across the company. The digital channel sales momentum was due to three levers: D2C bata e-store, marketplaces, and omni-channel home delivery.

Cost-focus initiatives to drive the quarterly results:

A direct result of focus on key areas of franchise and MBO expansion and digital footprint expansion is seen in the quarterly results. This is done continuous improvement in portfolio and marketing investments. Moreover, footfalls across retail outlets saw a significant spike, besides sales through digital channels. All the cost-focused initiatives, which have been put in place across multiple work streams, are showing increasing impact this quarter. Bata is witnessing a significant uptick in sales with rising demand for fashionable and comfortable footwear.

They continue to expand their reach through new franchise stores and multi-brand outlets. They have opened 20-plus new franchise stores, taking the total number to over 320, with a strong future pipeline and expanded availability via a distribution channel that continued to scale up to close to 1,100 towns. Almost 60+ stores renovated during the June quarter. Simultaneously, Bata also focused on driving volumes in these inflationary times, which should have an impact in the ensuing period.

In the face of volatile inflation and geopolitical unrest, they are cost efficient and accordingly planning cost-savings measures across their network, which has reflected in the profitability. They are continuing to flesh out new opportunities across all value chains, which will help them capture the emerging consumer demand efficiently. They continue to be optimistic about the momentum going ahead, driven by innovation, scaling up digital channels, expansion in Tier 3-5 towns, and productivity enhancement in brands and stores.

The Net Promoter Score (NPS), feedback for loyalty for all offline and online channels that Bata services, stood at 70%. It was the continued growth of the sneaker category that led to the growth recovery. The sneaker studio in 125 stores to display up to 300 styles across 9 brands. Bata continued with an expansion drive in tier 3–5 cities. The company continued to expand its distribution business in MBOs across 1100 towns.

Valuations:

The EPS was Rs. 22.7 for the June 2022 quarter. The ROCE was at 8.37%, whereas the ROE was at 5.74%. The EBITDA stood at 33.2x for Q1 FY23. The price to book value was at 13.6x. The P/E was at 84.9x, while the 5 year P/E was at 45.9x for Bata India Ltd. The return on assets was 2.99% for the same quarter. The shares of Bata India Ltd on Friday settled at Rs 1927, up 0.25% from the previous close.

0 Comment